Related Articles
LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway
TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway
Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway
Knockdown of CDK6 enhances glioma sensitivity to chemotherapy
Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells